Alcon Aktie

81,56CHF -1,98CHF -2,37%
Alcon für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A2PDXE / ISIN: CH0432492467
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 23 655 24 389 25 178 25 315 25 599
Umsatz pro Mitarbeiter in Mio. EUR 0,27 0,31 0,33 0,34 0,34

Bilanz (in Mio. CHF) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 4 408 4 907 4 805 4 753 5 718
Summe Anlagevermögen 19 989 20 604 22 220 20 172 21 784
Summe Aktiva 24 397 25 511 27 024 24 925 27 502

Bilanz (in Mio. CHF) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 7 759 7 966 8 819 7 566 7 970
Summe Eigenkapital 16 638 17 545 18 205 17 358 19 532
Summe Passiva 24 397 25 511 27 024 24 925 27 502

Adresse

Royce Bedward, 1214 Geneva
Telefon +41 (817) 293-04-50
Fax +41 (817) 916-26-52
Internet http://www.alcon.com

Management

Arthur Cummings
Independent Director
Bono Raquel Cruz
Director
D. Keith Grossman
Vice Chairman
Daniel E. Cravens
Investor Relations Contact
David J. Endicott
Chief Executive Officer & Director
Dieter Spälti
Independent Director
Edward McGough
Head-Global Manufacturing & Technical Operations
F. Michael Ball
Chairman
Franck Leveiller
SVP, Head-Global Research & Development
Heather Attra
Senior Vice President-Quality & Regulatory Affairs
Ian Bell
President-Global Business & Innovation
Ines Pöschel
Independent Director
Joe Rappon
VP-Pharmaceutical Research & Development
Karen J. May
Independent Director
Kim Martin
Chief Human Resources Officer & Senior VP
Laurent Attias
Head-Strategy & Business Development
Leon Sergio Duplan Fraustro
President-North America Division
Lynn Dorsey Bleil
Independent Director
Rajkumar Narayanan
President-International
Royce R. Bedward
Secretary, Senior Vice President & General Counsel
Scott Maw
Independent Director
Sue-Jean Lin
SVP, Chief Information & Transformation Officer
Thomas Heinrich Glanzmann
Independent Director
Timothy C. Stonesifer
Chief Financial Officer